FilingReader Intelligence
Jinyu Bio-Technology subsidiary wins veterinary drug approval
July 14, 2025 at 12:00 PM UTC•By FilingReader AI
Jinyu Bio-Technology announced its subsidiary Yangzhou Youbang Biological Pharmaceutical obtained approval for a new trivalent inactivated vaccine for chickens targeting Newcastle disease, avian influenza, and avian adenovirus.
The company invested approximately 6m yuan in developing the product, which has an 18-month shelf life and expands its poultry vaccine portfolio.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Jinyu Bio-Technology publishes news
Free account required • Unsubscribe anytime